As of December 31, 2025, Legend Biotech (LEGN) had approximately $949 million of cash and cash equivalents and time deposits.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEGN:
- Legend Biotech selloff brings favorable risk/reward, says Deutsche Bank
- LEGN Upcoming Earnings Report: What to Expect?
- Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target
- Legend Biotech rises 16.6%
- Legend Biotech downgraded to Neutral from Buy at Rothschild & Co Redburn